Repair of lipopolysaccharide-induced acute lung injury in mice by endothelial progenitor cells, alone and in combination with simvastatin

Chest

Volumn 144, Issue 3, 2013, Pages 876-886

  Li, Hao ^a   Qiang, Yong ^a   Wang, Lian ^a   Wang, Gaoming ^b   Yi, Jun ^a   Jing, Hua ^a   Wu, Haiwei ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; SIMVASTATIN;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CELL FUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL PROGENITOR CELL; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE REPAIR; TREATMENT OUTCOME;

EID: 84884343738     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2429     Document Type: Article

References (43)

1. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005 ; 353 (16): 1685-1693.
2. Serikov VB, Mikhaylov VM, Krasnodembskay AD, Matthay MA. Bone marrow-derived cells participate in stromal remodeling of the lung following acute bacterial pneumonia in mice. Lung. 2008 ; 186 (3): 179-190.
3. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001 ; 103 (5): 634-637.
4. Rafat N, Dacho C, Kowanetz G, et al. Therapeutic effects of endothelial progenitor cells in LPS-induced ARDS. Anasthesiologie & Intensivmedizin. 2012 ; 4 : 196-208.
5. Cribbs SK, Sutcliffe DJ, Taylor WR, et al. Circulating endothelial progenitor cells inversely associate with organ dysfunction in sepsis. Intensive Care Med. 2012 ; 38 (3): 429-436.
6. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JGN. Simvastatin attenuates vascular leak and infl ammation in murine infl ammatory lung injury. Am J Physiol Lung Cell Mol Physiol. 2005 ; 288 (6): L1026-L1032.
7. Shyamsundar M, McKeown STW, O'Kane CM, et al. Simvastatin decreases lipopolysaccharide-induced pulmonary infl ammation in healthy volunteers. Am J Respir Crit Care Med. 2009 ; 179 (12): 1107-1114.
8. O'Neal HR Jr, Koyama T, Koehler EAS, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011 ; 39 (6): 1343-1350.
9. Llevadot J, Murasawa S, Kureishi Y, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest. 2001 ; 108 (3): 399-405.
10. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002 ; 105 (25): 3017-3024.
11. Hu Z, Zhang F, Yang Z, et al. Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia. J Biomed Sci. 2008 ; 15 (4): 509-517.
12. Cui X, Chopp M, Zacharek A, et al. Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol Dis. 2009 ; 36 (1): 35-41.
13. Kim YS, Park HJ, Kwon JS, Jeong MH, Cho JG, Park JC, et al. The effects of simvastatin on homing of bone marrow stromal cells to infarcted myocardium in rats. Tissue Engineering and Regenerative Medicine. 2009 ; 6 (4): 1072-1076.
14. Janet CG, Joseph TB, John CD, et al. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: The National Academies Press ; 2011 : 1-208.
15. Alm A-S, Li K, Chen H, Wang D, Andersson R, Wang X. Varia tion of lipopolysaccharide-induced acute lung injury in eight strains of mice. Respir Physiol Neurobiol. 2010 ; 171 (2): 157-164.
16. Sadeghi MM, Collinge M, Pardi R, Bender JR. Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory G protein. J Immunol. 2000 ; 165 (5): 2712-2718.
17. Aliotta JM, Keaney PJ, Warburton RR, et al. Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension. Stem Cells Dev. 2009 ; 18 (5): 773-782.
18. Mathew B, Huang Y, Jacobson JR, et al. Simvastatin attenuates radiation-induced murine lung injury and dysregulated lung gene expression. Am J Respir Cell Mol Biol. 2011 ; 44 (3): 415-422.
19. Aguilar S, Scotton CJ, McNulty K, et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fi brosis. PLoS ONE. 2009 ; 4 (11): e8013.
20. Chen H, Bai C, Wang X. The value of the lipopolysaccharideinduced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 2010 ; 4 (6): 773-783.
21. Toya SP, Li F, Bonini MG, et al. Interaction of a specifi c population of human embryonic stem cell-derived progenitor cells with CD11b 1 cells ameliorates sepsis-induced lung infl ammatory injury. Am J Pathol. 2011 ; 178 (1): 313-324.
22. Aslam M, Baveja R, Liang OD, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med. 2009 ; 180 (11): 1122-1130.
23. Xu J, Qu J, Cao L, et al. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol. 2008 ; 214 (4): 472-481.
24. Jeon O, Song SJ, Bhang SH, Choi CY, Kim MJ, Kim BS. Additive effect of endothelial progenitor cell mobilization and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. J Biomed Sci. 2007; 14(3): 323-330.
25. Mao M, Wang SN, Lv XJ, Wang Y, Xu JC. Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats. Shock. 2010 ; 34 (2): 196-204.
26. Lam C-F, Roan J-N, Lee C-H, et al. Transplantation of endothelial progenitor cells improves pulmonary endothelial function and gas exchange in rabbits with endotoxin-induced acute lung injury. Anesth Analg. 2011 ; 112 (3): 620-627.
27. Gao X, Chen W, Liang Z, Chen L. Autotransplantation of circulating endothelial progenitor cells protects against lipopolysaccharide-induced acute lung injury in rabbit. Int Immunopharmacol. 2011 ; 11 (10): 1584-1590.
28. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007; 179(3): 1855-1863.
29. Huang YQ, Sauthoff H, Herscovici P, et al. Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Crit Care Med. 2008 ; 36 (1): 262-267.
30. Wu BJ, Midwinter RG, Cassano C, et al. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2009 ; 29 (10): 1537-1542.
31. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokinemediated infl ammation in acute lung injury. Cytokine Growth Factor Rev. 2003 ; 14 (6): 523-535.
32. Li XY, Donaldson K, Brown D, MacNee W. The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung infl ammation. Am J Respir Cell Mol Biol. 1995 ; 13 (2): 185-195.
33. Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fl uids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996 ; 125 (3): 191-196.
34. Comellas AP, Briva A. Role of endothelin-1 in acute lung injury. Transl Res. 2009 ; 153 (6): 263-271.
35. Kupatt C, Hinkel R, Lamparter M, et al. Retroinfusion of embryonic endothelial progenitor cells attenuates ischemiareperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase. Circulation. 2005; 112(9)(suppl): I117-I122.
36. Fujita M, Kuwano K, Kunitake R, et al. Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. Int Arch Allergy Immunol. 1998 ; 117 (3): 202-208.
37. Weil BR, Markel TA, Herrmann JL, Abarbanell AM, Kelly ML, Meldrum DR. Stem cells in sepsis. Ann Surg. 2009 ; 250 (1): 19-27.
38. Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001 ; 108 (3): 391-397.
39. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001; 103(24): 2885-2890.
40. Takano K, Yamamoto S, Tomita K, et al. Successful treatment of acute lung injury with pitavastatin in septic mice: potential role of glucocorticoid receptor expression in alveolar macrophages. J Pharmacol Exp Ther. 2011 ; 336 (2): 381-390.
41. Infusino GA, Jacobson JR. Endothelial FAK as a therapeutic target in disease. Microvasc Res. 2012 ; 83 (1): 89-96.
42. Takahashi S, Nakamura H, Seki M, et al. Reversal of elastaseinduced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. Am J Physiol Lung Cell Mol Physiol. 2008 ; 294 (5): L882-L890.
43. Chen W, Pendyala S, Natarajan V, Garcia JGN, Jacobson JR. Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. Am J Physiol Lung Cell Mol Physiol. 2008 ; 295 (4): L575-L583.